Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Callitas Health Inc MPHMF

Callitas Health Inc is a Canada-based company that is primarily engaged in integrated clinical-stage pharmaceutical development and over-the-counter (OTC) consumer goods marketing. The Company provides biomedical technologies and products. The Company offers drug treatments for obesity, infertility, intimacy issues, weight management, female sexual dysfunction solutions and women wellness.


GREY:MPHMF - Post by User

Bullboard Posts
Post by Third3yeon Sep 20, 2017 9:21am
71 Views
Post# 26718451

Form 12

Form 121. Provide full details of the reclassification: Callitas Health Inc, formerly M Pharmaceutical Inc., consolidated its issued and outstanding share capital on the basis of 10 current shares for one new share in conjunction with the change of name to Callitas Health Inc. The effective date of the consolidation was September 12, 2017. The shares begin trading on a consolidated basis under the new symbol LILY on Thursday, September 21, 2017. No fractional shares will be issued. All fractional shares resulting from the consolidation will be rounded to the nearest whole number. A letter of transmittal will be sent to each shareholder outlining the procedure to exchange share certificates. The Corporation will have approximately 26,212,092 common shares outstanding subsequent to the consolidation. 2. Number of securities outstanding and reserved for issuance following the reclassification Issued/Outstanding: 32,462,095
Bullboard Posts